Projects per year
Personal profile
Education
- 1993-1995 M.S., Institute of Preventive Medicine, College of Public Health, National Taiwan University
- 1986-1993 M.D., School of Medicine, College of Medicine, National Taiwan University
Experience
- 2020.02- Professor, Masters and Ph.D. programs of Mind Brain and Consciousness, Taipei Medical University
- 2012.08- Professor, Department of Psychiatry, Taipei Medical University
- 2009 Chief, Department of Psychiatry, Taipei Medical University-Wan Fang Hospital
- 2009.08-2012.07 Associate Professor, Department of Psychiatry, Taipei Medical University
- 2007.08- Assistant Professor, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2005.02-2009.07 Assistant Professor, Department of Psychiatry, Taipei Medical University
- 2001 Lecturer, Department of Psychiatry, Taipei Medical University
- 2000 Staff Psychiatrist, Department of Psychiatry, Taipei Medical University-Wan Fang Hospital
- 1999 Staff Psychiatrist, Department of Psychiatry, Shin Kong Wu Ho-Su Memorial Hospital
- 1998 Chief Resident, Taipei City Psychiatric Center
- 1995 Resident, Taipei City Psychiatric Center
Awards
- 2005 Shi-Jin Tsai Memorial Award (Young Investigator Award), Taiwanese Society of Psychiatry
- 2005 Schizophrenia Research Award, Taiwanese Society of Psychiatry
- 2005 Travel Award, Joint Meeting of the 27th Japanese Society of Biological psychiatry and the 35th Japanese Society of Neuropsychopharmacology, Osaka, Japan
- 2007 Ta-You Wu Memorial Award (Young Investigator Award), National Science Council
- 2008 Young Investigator Award, Taipei Medical University
- 2008 Best Research Award, Taipei Medical University
- 2010 Young Scientist Travel Award, The 5th Annual Meeting of Japanese Society of Schizophrenia Research, Fukuoka, Japan
Research Interests
- Psychiatry, Psychopharmacology, Clinical trial
Fingerprint
Dive into the research topics where Mong-Liang Lu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Metformin for the Treatment of Antipsychotic-Induced Hyperprolactinemia in Patients with Schizophrenia: a Randomized, Placebo-Controlled, Double-Blind Trial
Lu, M.-L. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Metformin for the Treatment of Antipsychotic-Induced Hyperprolactinemia in Patients with Schizophrenia: a Randomized, Placebo-Controlled, Double-Blind Trial
Lu, M.-L. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
A Randomized Sham-Controlled Clinical Trial of Transcranial Alternating Current Stimulation in the Treatment of Schizophrenia
Lu, M.-L. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
A Randomized Sham-Controlled Clinical Trial of Transcranial Alternating Current Stimulation in the Treatment of Schizophrenia
Lu, M.-L. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
A Randomized Sham-Controlled Clinical Trial of Transcranial Alternating Current Stimulation in the Treatment of Schizophrenia
Lu, M.-L. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
Efficacy of pharmacological and nutritional interventions for glucose dysfunction in schizophrenia—A systematic review and network meta-analysis
Liu, C. I., Lin, L. W., Tsai, Y. J., Lu, M. L., Chen, C. & Goh, K. K., 2026, In: Journal of Psychopharmacology.Research output: Contribution to journal › Article › peer-review
-
Longitudinal associations among childhood trauma, oxytocin, and metabolic risk in schizophrenia
Goh, K. K., Chen, P. Y., Chang, H. M., Kanahara, N., Chen, C., Cheng, M. H., Yang, C. T. & Lu, M. L., Jun 2026, In: Psychiatry Research. 360, 117088.Research output: Contribution to journal › Article › peer-review
-
Oxytocin mediates self–other and inevitability asymmetries in high-conflict moral judgment in schizophrenia
Cheng, M. H., Goh, K. K., Lu, M. L., Wang, C. H., Chuang, J. Y., Chen, C. & Yang, C. T., Jul 2026, In: Asian Journal of Psychiatry. 121, 105015.Research output: Contribution to journal › Article › peer-review
Open Access -
The U-shaped relationships between prolactin level and insulin resistance in patients with schizophrenia under olanzapine treatment
Goh, K. K., Wu, T. H., Chen, C. H., Chen, P. Y. & Lu, M. L., Sept 2026, In: Schizophrenia Research. 295, p. 202-209 8 p.Research output: Contribution to journal › Article › peer-review
-
Associations between paraoxonase-1 activity and therapeutic drug monitoring indicators in schizophrenia patients treated with olanzapine: A cross-sectional study
Wu, T. H., Hu, S. C., Sylfa, N., Liao, J. H., Raza, A., Chen, B. L., Chen, C. H. & Lu, M. L., 2025, (Accepted/In press) In: Journal of Psychopharmacology. 39, 2, p. 141-146 6 p.Research output: Contribution to journal › Article › peer-review
Datasets
-
Supplement_3 – Supplemental material for Lamotrigine augmentation in treatment-resistant unipolar depression: A comprehensive meta-analysis of efficacy and safety
Goh, K. K. (Contributor), Chen, C.-H. (Contributor), Chiu, Y.-H. (Contributor) & Lu, M.-L. (Contributor), Figshare, 2019
DOI: 10.25384/sage.8185616.v1, https://doi.org/10.25384%2Fsage.8185616.v1
Dataset
-
Lamotrigine augmentation in treatment-resistant unipolar depression: A comprehensive meta-analysis of efficacy and safety
Goh, K. K. (Contributor), Chen, C.-H. (Contributor), Chiu, Y.-H. (Contributor) & Lu, M.-L. (Contributor), Figshare, 2019
DOI: 10.25384/sage.c.4518176.v1, https://doi.org/10.25384%2Fsage.c.4518176.v1
Dataset
-
Topiramate mitigates weight gain in antipsychotic-treated patients with schizophrenia: meta-analysis of randomised controlled trials
Chen, C.-H. (Contributor), Lu, M.-L. (Contributor) & Goh, K. K. (Contributor), Taylor & Francis, 2018
DOI: 10.6084/m9.figshare.6004622.v1, https://doi.org/10.6084%2Fm9.figshare.6004622.v1
Dataset
-
sj-docx-1-jop-10.1177_0269881120981392 – Supplemental material for Effects of omega-3 polyunsaturated fatty acids supplements on psychopathology and metabolic parameters in schizophrenia: A meta-analysis of randomized controlled trials
Chen, C.-H. (Creator), Chen, C.Y.-A. (Creator), Lu, M.-L. (Contributor) & Goh, K. K. (Contributor), SAGE Journals, 2021
DOI: 10.25384/sage.14045192.v1, https://doi.org/10.25384%2Fsage.14045192.v1
Dataset
-
sj-docx-5-jop-10.1177_0269881120981392 – Supplemental material for Effects of omega-3 polyunsaturated fatty acids supplements on psychopathology and metabolic parameters in schizophrenia: A meta-analysis of randomized controlled trials
Lu, M.-L. (Contributor), Chen, C.-H. (Creator), Chen, C.Y.-A. (Creator) & Goh, K. K. (Contributor), SAGE Journals, 2021
DOI: 10.25384/sage.14045204.v1, https://doi.org/10.25384%2Fsage.14045204.v1
Dataset